In the first half of the year, Douyin E-commerce preemptively intercepted over 370,000 cases of medical device violations; Dentsply Sirona, Envista, Solventum, and Henry Schein, Inc. released financi…

GF MEDICAL GROUP Named 2026 Jiangsu Advanced-Level Intelligent Factory, with Cumulative Investment Exceeding RMB 100 Million to Advance Dental Device Digitalization

Recently, the Jiangsu Provincial Department of Industry and Information Technology released the "Public Notice on the Proposed List for the 2026 Jiangsu Advanced-Level Intelligent Factories." Gaofeng Medical Devices (Wuxi) Co., Ltd. was successfully selected for its project, "Intelligent Factory for Oral Medical Device Manufacturing Featuring Networked Collaboration and Intelligent Flexible Production."

It is reported that since 2022, GF MEDICAL GROUP has initiated the construction of its intelligent factory, focusing on the personalized customization needs of oral medical devices, with cumulative investment exceeding RMB 100 million. On the production front, GF MEDICAL GROUP has introduced intelligent flexible equipment such as milling-turn composite machining centers. On the R&D front, it has applied EXOCAD dental restoration digital tools and a full-process product data system. For network architecture, it has adopted a heterogeneous integration solution combining "workshop fieldbus + industrial Ethernet + 5G." Additionally, its unified digital production management platform integrates functions for production planning, manufacturing execution, and quality traceability, and deploys industrial firewalls, intrusion detection systems, and a security situational awareness platform.

Following the system's implementation, GF MEDICAL GROUP has achieved significant improvements in the numerical control rate of key equipment, production efficiency, and sales figures. Operating costs per unit of output value and comprehensive energy consumption have notably decreased, the product defect rate has been effectively reduced, and the on-time delivery rate for suppliers and orders has approached 100%.

Envista 2026 Q2: Revenue of $730 Million, Spark Orthodontics Business Maintains Double-Digit Growth

On August 5, 2026, Envista Holdings released its second-quarter results for 2026, with revenue of $730.5 million, a year-over-year increase of 7.1%, and core sales growth of 5.0%. The Spark orthodontics business maintained double-digit growth. Adjusted EBITDA margin improved to 14.7%. The company raised its full-year core sales growth target to 3.5%-4.5% and its adjusted EBITDA growth target to 11%-14%. Cumulative revenue for the first half of the year was $1.436 billion, with adjusted EBITDA of $206.6 million.

Dentsply Sirona 2026 Q2: Revenue of $898 Million, Gross Margin Improved to 54.9%

On August 6, 2026, Dentsply Sirona announced its second-quarter results for fiscal 2026, with quarterly net sales of $898 million, a year-over-year decrease of 4.1%. GAAP gross margin was 54.9%, an improvement of 2.5 percentage points from 52.4% in the same period last year. Adjusted gross margin was 56.4%, up 0.5 percentage points from 55.9% in the prior-year period. Adjusted EBITDA was $190 million, and operating cash flow was $99 million. The company repurchased 1.3 million shares for approximately $12 million and held $239 million in cash and equivalents as of June 30.

Solventum 2026 Q2: Dental Business Revenue of $396 Million, Up 17.0% Year-Over-Year

On August 5, 2026, Solventum released its Q2 2026 financial results. During the reporting period, the company achieved revenue of $2.209 billion, a year-over-year increase of 2.2%, with organic growth reaching 9.5%. Net profit attributable to shareholders of the parent company was $92 million, up 2.2% year-over-year. The Dental Solutions segment generated revenue of $396 million in the quarter, a 17.0% increase year-over-year. On a cumulative basis for the first half of 2026, the Dental Solutions segment achieved revenue of $750 million, up 12.5% year-over-year.

Henry Schein 2026 Q2: Global Dental Distribution Revenue of $1.854 Billion, Up 8.1% Year-Over-Year

On August 4, 2026, Henry Schein, Inc. released its second-quarter 2026 financial results, with quarterly revenue of $3.458 billion, a year-over-year increase of 6.7%. Global Dental Distribution revenue was $1.854 billion, an increase of 8.1%. Net income attributable to shareholders was $94 million, up 9.1%. During the quarter, the company repurchased approximately 2.6 million shares of common stock at an average price of $76.69, with $455 million remaining under its authorized repurchase program.

3D Systems 2026 Q2: Net Loss of $12.9 Million Attributable to Parent Company, Dental Business Up 3% Year-Over-Year

On August 3, 2026, 3D Systems released its second-quarter 2026 financial results: revenue was $94.6 million, with a net loss of $12.9 million attributable to the parent company. Healthcare solutions revenue was $48.1 million, up 6.8% year-over-year, making it the largest business segment. The Dental business grew 3% year-over-year, while Med Tech business grew over 20%.

COLTENE: 2026 H1 Sales Approximately RMB 941 Million, Establishes Dental Joint Venture in China

On July 31, 2026, COLTENE announced its first-half 2026 results, achieving net sales of RMB 941 million. EBIT was CHF 5.753 million (approximately RMB 47.977 million), with the EBIT margin falling to 5.1% and a gross margin of 65.0%. The company established a tooth preservation joint venture in Changshu, China, holding a 65% stake, focusing on the local market. The company reaffirmed its 2028 targets of achieving 3%-5% organic sales growth and a 13%-15% EBIT margin.

Sinocera 2026 H1: Revenue of RMB 2.513 Billion, Up 16.6%; Biomedical Segment Revenue Up 21.96%

On August 6, 2026, Shandong Sinocera Functional Material Co., Ltd. released its 2026 semi-annual report, with operating revenue of RMB 2.513 billion, a year-over-year increase of 16.64%. Revenue from the biomedical materials segment was RMB 534 million, with a growth rate of 21.96%. Net operating cash flow was RMB 456 million, up 36.78%. The company completed the acquisition of Australian dental company SDI Limited. As of the end of the reporting period, total assets were RMB 10.843 billion, and net assets attributable to the parent company were RMB 7.330 billion.

Dongguan Dental Clinic Fined RMB 60,000 for Falsifying Group-Buying Project Prices and Gift Values

On July 15, 2026, a dental clinic in Guancheng, Dongguan, launched low-priced group-buying packages on online platforms and promoted physical gifts valued at RMB 100,000, while the actual gift value was only RMB 34,700. After verification, regulatory authorities determined that this constituted price fraud and fictitious gift value, and imposed a fine of RMB 60,000 on the institution in accordance with the Price Law.

Douyin E-commerce Conducts Special Governance for Medical Categories, Pre-Intercepting Over 370,000 Violations

On August 4, 2026, the Douyin E-commerce Safety and Trust Center announced that since February 2026, it has conducted special governance targeting the Pharmaceutical and Medical Device Categories. Over six months, it has pre-intercepted more than 370,000 violations cumulatively, involving actions such as misplacement of pharmaceutical products and false advertising. The platform has added new identification models and strictly regulated the product listing process. Previously, Douyin Medical released new regulations in September 2024 to strengthen medical content management and strictly control false information and improper traffic diversion.

ADSO Sues Colorado Dental Board, Seeking to Overturn New Rule Restricting DSO Clinic Ownership

On July 30, 2026, the Association of Dental Support Organizations (ADSO) filed a lawsuit in court challenging Rule 1.7 newly passed by the Colorado Dental Board, which prohibits DSOs from holding ownership or related interests in dental practices. ADSO stated that this rule could weaken the ability of DSO-supported practices to provide oral care to Medicaid patients. ADSO pointed out that the restriction would increase operating costs and affect service coverage, and has requested the court to temporarily stay the enforcement of relevant provisions during the proceedings.

Dental AI Technology Company Relu Receives Strategic Investment from DIA

On August 4, 2026, dental AI company Relu received a $1.75 million strategic investment from the Dental Innovation Alliance (DIA) to accelerate its AI laboratory automation expansion in the United States. Relu's Relu® Automate platform supports design across multiple scenarios including dental models, crowns, and orthodontic models. Its Creator tool can generate 3D anatomical models from medical imaging and has received FDA and CE certification. The company's business covers 82 countries, processing over 1 million cases annually. In 2023, it completed a EUR 2 million seed round financing. Relu was founded in 2019, is headquartered in Belgium, and has a business team in Boston, USA.

US Implant-Focused DSO Receives Minority Investment from M-One, Aiming to Become One of the Largest Implant Platforms Nationwide

On August 5, 2026, Shared Practices Group (SPG), a US dental service organization focused on dental implants, received a minority equity investment from M-One Capital. The capital will be used to expand its network of 48 partner clinics across 26 states, enhancing technology, operations, and marketing capabilities. Dr. Alex Sharp, CEO of SPG, stated that this collaboration aims to drive SPG to become one of the largest dental implant service platforms in the United States. As of press time, SPG has not disclosed the specific valuation or transaction closing timeline for this financing round.

New Data: Number of Registered Dentists in Northern Ireland Drops to 1,174 in 2026 Q1, with an Average of 795 Patients per Dentist

On August 3, 2026, the Northern Ireland Statistics and Research Agency released the dental services report for the first quarter of 2026. Patient registrations totaled 933,427, a year-over-year decrease of 3.4%. There were 1,174 dentists, a 1.5% decrease year-over-year, with each dentist responsible for approximately 795 patients on average. The province had 349 dental clinics, a quarter-over-quarter decrease of 0.6%. Treatment claims in the quarter totaled 235,379, up 2.6% quarter-over-quarter. IOS treatment expenditure was GBP 16,691,000, up 4.8% quarter-over-quarter. The decline in this indicator is primarily affected by the reduction in patient registrations and cannot be used alone as a basis for judging improvements in dental service supply.

New Study: Silver Diamine Fluoride Can Stop Cavity Progression in Young Children Without Drilling

On July 27, 2026, a multicenter study involving the University of Michigan and New York University was published in JAMA Pediatrics. The randomized controlled trial showed that a single application of 38% silver diamine fluoride (SDF) increased the lesion arrest rate to 54.0% in 6-month-old children, significantly higher than the 22.5% observed with placebo. This result provides key data to support FDA approval of SDF for caries management in children, contributing to the low-cost, non-invasive pediatric dental treatment options that oral health professionals worldwide are focusing on.

New Therapy May Eliminate Gum Disease Bacteria While Preserving Beneficial Oral Microbes

Recently, the Near Infrared Photo-Antibacterial Targeting Therapy (NIR-PAT²) developed by Nagoya University achieved selective elimination of Porphyromonas gingivalis in in vitro and mouse Periodontitis Models. LPS release was significantly reduced, alveolar bone resorption was inhibited, and the oral microbiota shifted towards a healthier composition. The study indicates that this technology utilizes IgY antibodies conjugated with the photosensitizer dye IR700, which generates physical pressure on the bacterial cell membrane upon light exposure while maintaining overall structural integrity. This remains at the experimental stage, and conclusions from animal studies cannot be directly extrapolated to human clinical applications, requiring further clinical trials for verification.